image
Actor portrayal of TUKYSA (tucatinib) patient and loved ones on a wooden boardwalk, the woman framing a photo of themselves with her hands, representative of the TUKYSA (tucatinib) logomark.
Mobile_image
Actor portrayal of TUKYSA (tucatinib) patient and loved ones on a wooden boardwalk, the woman framing a photo of themselves with her hands, representative of the TUKYSA (tucatinib) logomark.
headline

I take the TUKYSA® (tucatinib) regimen* for me, and them

content
*TUKYSA regimen: TUKYSA, trastuzumab, capecitabine

Not real patients.
image
Graphic showing TUKYSA (tucatinib) bottle, trastuzumab infusion bag, and capecitabine tablets illustrated side by side with plus symbols
headline

What is TUKYSA?

subheadline
TUKYSA is a targeted oral treatment taken as a part of a regimen, which includes trastuzumab and capecitabine
content
TUKYSA is approved for adults with HER2+ MBC who have already received one or more treatments that target HER2, such as trastuzumab, pertuzumab, or ado-trastuzumab emtansine.
image
Diagram showing TUKYSA (tucatinib) targeting HER2 from inside the cell and trastuzumab targeting HER2 from outside the cell. See Important Safety Information.
headline

How does TUKYSA work?

subheadline
TUKYSA + trastuzumab target HER2 in 2 ways
content
Together, they are each designed to more completely block the signal that tells cancer cells to grow than either therapy alone.

Since HER2 is also present on normal cells, HER2-targeted therapies like TUKYSA can affect normal cells, causing side effects. Some side effects may be serious.
headline

Watch to learn about TUKYSA: Benefits, side effects, and more

video_id

6394348842112

account_id
1852113022001
title
BE EMPOWERED IN YOUR CONVERSATIONS
poster
TUKYSA (tucatinib) video thumbnail.
load
slow